We therefore used the same GFP-AnxA2 and GFP-AnxA6 transfected breast carcinoma cells to determine which of these two family members is capable of translocating to the late endosomes in the absence and in the presence of added exosomes. This evidence concerns the gene ANXA6 and breast carcinoma.